Advertisement
Fidelity Select Biotechnology Portfolio

Fidelity Select Biotechnology Portfolio (FBIOX) Stock Overview

Explore Fidelity Select Biotechnology Portfolio’s financial performance, market position, analyst ratings, and future outlook.

FBIOXNASDAQ
HealthcareBiotechnology
$24.56
$0.44(1.82%)
U.S. Market opens in 16h 8m
Advertisement

Fidelity Select Biotechnology Portfolio (FBIOX)

Meyka AI Score

Z

Key Financials

Market Cap5.2B
P/E RatioN/A
EPS (TTM)N/A
ROE0.00%
Fundamental Analysis

AI Price Forecasts

1 Month$26.43
3 Months$28.21
1 Year Target$27.85

FBIOX Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Fidelity Select Biotechnology Portfolio (FBIOX) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 44.34, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $27.85.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of N/A and a market capitalization of 5.2B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
1.82%
5-Day Change
-3.99%
1-Month Change
-2.03%
3-Month Change
-5.50%
6-Month Change
-5.06%
Year-to-Date (YTD) Change
-2.27%
1-Year Change
36.07%
3-Year Change
44.90%
5-Year Change
16.34%
All-Time (Max) Change
2356.00%

Contact Information

800-544-8544
Fidelity Select Portfolios, NaN, MA, NaN

Company Facts

IPO DateDec 16, 1985
CountryUS
Actively Trading

Frequently Asked Questions